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Klotho, a hormone and enzyme, is a powerful regulator of ageing and life span. Klotho deﬁciency
leads to cardiac arrythmia and sudden cardiac death. We thus explored whether klotho modiﬁes
cardiac K+-channel hERG. Current was determined utilizing dual electrode voltage clamp and hERG
protein abundance utilizing immunohistochemistry and chemiluminescence in Xenopus oocytes
expressing hERG with or without klotho. Coexpression of klotho increased cell membrane
hERG-protein abundance and hERG current at any given voltage without signiﬁcantly modifying
the voltage required to activate the channel. The effect of klotho coexpression was mimicked by
recombinant klotho protein and reversed by b-glucuronidase-inhibitor D-saccharic acid-1,4-lactone.
 2013 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.1. Introduction
Klotho, a protein expressed in several tissues including kidney,
parathyroid glands and choroid plexus [1,2], has a profound inﬂu-
ence on ageing and life span [3,4]. Klotho deﬁcient mice suffer from
severe growth retardation as well as accelerated appearance of a
wide variety of age related disorders and eventually die within less
than 5 months [4]. Conversely, the life span of klotho-overexpress-
ing mice is substantially prolonged [3,4]. The extracellular domain
of klotho may be cleaved off and inﬂuence target cells by its action
as glucuronidase or hormone [5].
Klotho participates in the inhibitory effect of FGF23 on 1a-
hydroxylase resulting in decreased formation of 1,25(OH)2D3
[1,3,6,7]. Since 1,25(OH)2D3 is a powerful regulator of intestinal
and renal Ca2+ and phosphate transport [8,9], the excessive
1,25(OH)2D3 formation in klotho deﬁcient mice results in a marked
increase of plasma Ca2+ [10] and phosphate [9] concentrations with
subsequent vascular calciﬁcation [11], growth deﬁcit [1] and pre-
mature erythrocyte death [12].
Klotho is further known to modify ion channels, carriers and
pumps in the cellular plasma membrane, including Na+, phosphate
cotransporters [13,14], Na+/K+ ATPase [15], Ca2+ channels [16] and
renal outer medullary K+ channels [17]. Klotho insufﬁciency results
in cardiac arrhythmia and sudden cardiac death [2], which couldpotentially have resulted from deranged klotho-dependent regula-
tion of cardiac ion channels.
The present study thus explored whether klotho participates in
the regulation of the human ether-a-go-go (hERG) channel, a key
channel accomplishing cardiac repolarisation [18,19] and partici-
pating in the deranged excitation following cardiac hypertrophy
[20]. hERG is further known to foster proliferation of several tu-
mour cells [21–23]. In order to possibly disclose an inﬂuence of
klotho on hERG channels, hERG was expressed in Xenopus oocytes
with or without additional expression of klotho. The results reveal
that coexpression of klotho up-regulates hERG activity by enhanc-
ing the plasma membrane abundance of the channel protein. The
effect is mimicked by treatment of hERG expressing Xenopus oo-
cytes with recombinant klotho protein. Conversely, the current in
hERG and klotho expressing Xenopus oocytes is down-regulated
by treatment with b-glucuronidase-inhibitor D-saccharic acid-1,4-
lactone (DSAL).
2. Materials and methods
2.1. Experiments in Xenopus oocytes
For generation of cRNA, constructs were used encoding klotho
[13] and hERG [24]. The cRNA was generated as described previ-
ously [25]. For voltage clamp analysis, Xenopus oocytes were pre-
pared as previously described [26]. Oocytes were injected with
water and 7.5 ng cRNA encoding hERG with and without 10 ng
cRNA encoding klotho. Standard two electrode voltage clamp
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oocytes were maintained at 17 C in a solution containing (in
mM) 88.5 NaCl, 2 KCl, 1.8 CaC12, 1 MgC12, 5 HEPES, 0.11 tretracy-
cline, 0.004 ciproﬂoxacin, 0.22 gentamycin (Refobacin ), 0.5 the-
ophylline (Euphylong ) as well as 5 sodium pyruvate. The pH was
adjusted to 7.4 by addition of NaOH. Oocytes were superfused con-
tinuously with ND-96 buffer containing (mM): NaCl 96, KCl 2,
CaCl2 1.8, MgCl2 1 and HEPES 5 (pH 7.4 with NaOH). Pipettes were
ﬁlled with 3 M KCl and had resistances of 0.5–1.0 MX. The data
were ﬁltered at 1 kHz and the experiments were performed with
a Geneclamp 500 ampliﬁer (Axon Instruments, Union City, CA,
USA) and a Digidata 1322A interface (Axon Instruments, Union
City, CA, USA) [28]. Data acquisition was achieved with pCLAMP
9.02 (Axon Instruments, Union City, CA, USA) and the data analysis
was performed with Clampﬁt 9.2 (Axon Instruments) software.
Where indicated, the experiments were performed in Xenopus oo-
cytes treated with either, recombinant klotho protein (24 h, 30 ng/
ml) or D-saccharic acid-1,4-lactone (DSAL, 24 h, 10 lM). Leak cur-
rents estimated from the tail current measured after the precondi-
tioning prepulse to 80 mV were subtracted. For normalization,
the individual tail currents at +70 mV were divided by the mean
tail current at +70 mV of oocytes expressing hERG alone.
2.2. Detection of hERG surface expression by chemiluminescence
For detection of hERG cell surface expression by chemilumines-
cence, the oocytes were ﬁrst incubated with 1 lg/ml primary rat(2) 
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Fig. 1. Effect of klotho coexpression on current in hERG expressing Xenopus oocytes. (A)
hERG alone (3) or coexpressing hERG and klotho (4). The pulse protocol is illustrated in
voltages followed by a 500 ms pulse to 60 mV evoking outward tail currents. (B) Arithm
a function of voltage in oocytes injected with water (grey diamonds), with cRNA encoding
means ± S.E.M. (n = 19–37) of the normalized tail current following a depolarization to
hERG (white bar) or with cRNA encoding hERG and klotho (black bar). ⁄⁄⁄ indicates statmonoclonal anti-HA antibody (clone 3 F10, Roche, Mannheim, Ger-
many) and subsequently with secondary, HRP-conjugated goat
anti-rat IgG antibody (1:1000, Cell Signaling Technology, MA,
USA). Individual oocytes were placed in 96 well plates with 20 ll
of SuperSignal ELISA Femto Maximum Sensitivity Substrate
(Pierce, Rockford, IL, USA) and chemiluminescence of single oo-
cytes was quantiﬁed in a luminometer (WalterWallac 2 plate read-
er, Perkin Elmer, Juegesheim, Germany) by integrating the signal
over a period of 1 s [29]. Results display relative light units. Integ-
rity of the measured oocytes was assessed by visual control after
the measurement to avoid unspeciﬁc light signals from the cytosol.
2.3. Immunostaining and confocal microscopy
To visualize hERG-HA cell surface expression, oocytes were
ﬁxed in 4% paraformaldehyde/PBS for at least 2 h at room temper-
ature [30]. After washing with PBS, the oocytes were cryoprotected
in 30% sucrose, frozen in mounting medium and placed on a cryo-
stat. Sections were collected at a thickness of 8 lm on coated slides
and stored at20 C. For immunostaining, sections were thawed at
room temperature, ﬁxed in aceton/methanol (1:1), washed in PBS
and blocked for 1 h in 5% bovine serum albumin in PBS. Sections
were incubated overnight at 4 C with 1 lg/ml primary rat mono-
clonal anti-HA antibody (clone 3 F10, Roche, Mannheim, Germany).
Binding of primary antibody was visualised with ﬂuorescence-la-
belled secondary Alexa Fluor 488 anti-rat IgG (1:200, Invitrogen,
UK) for 1 h at room temperature. The slides were mounted with0 
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Original tracings recorded in oocytes injected with water (2), with cRNA encoding
(1): The oocytes were depolarized from a holding potential of 80 mV to different
etic means ± S.E.M. (n = 19–37) of the normalized leak-corrected peak tail current as
hERG (white circles) or coexpressing hERG and klotho (black circles). (C) Arithmetic
+70 mV recorded in oocytes injected with water (dotted bar), with cRNA encoding
istical signiﬁcant (P < 0.001) difference to oocytes expressing hERG alone.
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on a Zeiss LSM 510 EXCITER Confocal Laser Scanning Microscope
(Carl Zeiss MicroImaging GmbH, Germany) with A-Plan 40/
1.2 W. Brightness and contrast settings were kept constant during
imaging of all oocytes in each injection series.
2.4. Statistical analysis
Data are provided as arithmetic means ± S.E.M; n represents the
number of oocytes or cells investigated. All oocyte experiments
were repeated with at least three batches of oocytes; in all repeti-
tions, qualitatively similar data were obtained. All data were tested
for signiﬁcance by using ANOVA. Results with P < 0.05 were con-
sidered statistically signiﬁcant.
3. Results
In order to test whether klotho modiﬁes the current generated
by hERG channels, cRNA encoding hERG was injected into Xenopus
oocytes with or without cRNA encoding klotho. As illustrated in
Fig. 1, in hERG expressing but not in water-injected Xenopus oo-
cytes depolarisations (500 ms) from a holding potential of
80 mV followed by repolarizations to 60 mV evoked character-
istic hERG outward tail currents. The additional expression of klo-
tho resulted in a marked increase of the hERG tail current.
Normalization of the tail currents to the maximum peak tail cur-
rent of the respective group reveals that coexpression of klotho
did not signiﬁcantly modify the voltage required to activate the
channels. The voltage of half maximal peak tail current was similar
in Xenopus oocytes expressing hERG alone and in Xenopus oocytes
expressing hERG with klotho.hERWater 
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Fig. 2. Effect of klotho coexpression on hERG protein abundance in the cell membrane of
membrane of Xenopus oocytes injected with water (left panel) or expressing hERG wi
subjected to immunoﬂuorescence staining using a FITC-conjugated antibody (green). (B)
chemiluminescence in the plasma membrane of Xenopus oocytes injected with water (
expression of klotho. ⁄ indicates statistical signiﬁcant (p<0.05) difference from oocytes eThe effect of klotho could have resulted from an increase of
hERG protein abundance in the cell membrane. Confocal micros-
copy and chemiluminescence were thus employed to quantify
hERG protein abundance in the cell membrane. To this end, HA-
tagged hERG was expressed in Xenopus oocytes and binding of
HA-speciﬁc antibody visualized by confocal microscopy and quan-
tiﬁed by chemiluminescence (Fig. 2). Due to unspeciﬁc staining,
considerable chemiluminescence was observed even in water in-
jected oocytes and the expression of hERG led only to a moderate
increase of HA-dependent staining in confocal microscopy and in-
crease of chemiluminescence. Nevertheless, the coexpression of
klotho resulted in a signiﬁcant increase of hERG channel protein
abundance in the plasma membrane (Fig. 2).
Further experiments were performed to test whether the effect
of klotho expression could be mimicked by treatment of hERG
expressing Xenopus oocytes with recombinant klotho protein. As
illustrated in Fig. 3, the treatment of hERG expressing Xenopus oo-
cytes with klotho protein for 24 h was followed by a signiﬁcant in-
crease of the hERG induced tail current. Similar to what has been
observed following coexpressing klotho in hERG expressing Xeno-
pus oocytes, the treatment of hERG expressing Xenopus oocytes
with klotho protein increased the maximal peak current values
but did not signiﬁcantly modify the voltage required for activation
of hERG channels.
As klotho is known to be effective as a glucuronidase [5] mod-
ifying the stability of proteins in the cell membrane [31], the effect
of the klotho inhibitor DSAL was tested on tail currents in Xenopus
oocytes expressing both, hERG and klotho. As illustrated in Fig. 4,
the treatment of hERG and klotho expressing Xenopus oocytes with
the klotho inhibitor d-saccharic acid-1,4-lactone (DSAL, 10 lM) for
a one day period signiﬁcantly decreased the absolute peak currentG-HA hERG-HA Klotho 
ERG hERG Klotho 
* 
20µm
Xenopus oocytes. (A) Confocal microscopy of hERG protein abundance in the plasma
thout (middle panel) or with (right panel) treatment with klotho. The cells were
Arithmetic means ± S.E.M. (n = 35–63) of hERG protein abundance as determined by
dotted bar) or expressing hERG without (white bar) or with (black bar) additional
xpressing hERG-HA alone.
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Fig. 3. Effect of treatment with klotho protein on current in hERG expressing Xenopus oocytes. (A) Original tracings recorded in oocytes injected with water (2), expressing
hERG without treatment (3) or treated for 24 h (4) with human recombinant klotho protein (30 ng/ml). The pulse protocol is illustrated in (1): the oocytes were depolarized
from a holding potential of 80 mV to different voltages followed by a 500 ms pulse to 60 mV evoking outward tail currents. (B) Arithmetic means ± S.E.M. (n = 9–18) of the
normalized leak-corrected peak tail current as a function of voltage in oocytes injected with water (grey diamonds), or injected with cRNA encoding hERG without (white
circles) or with (black circles) treatment for 24 h with human recombinant klotho protein. (C) Arithmetic means ± S.E.M. (n = 9–18) of the normalized tail current following a
depolarization to +70 mV recorded in water injected oocytes (dotted bar), or in hERG expressing oocytes without treatment (white bar) or treated (black bars) with
recombinant klotho protein (24 h, 30 ng/ml). ⁄⁄⁄ indicates statistical signiﬁcant (P < 0.001) difference from oocytes expressing untreated hERG.
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hERG channels.
4. Discussion
The present observations reveal a novel function of klotho, i.e.,
the regulation of hERG channel activity. According to dual elec-
trode voltage clamp in hERG channel expressing Xenopus oocytes,
klotho signiﬁcantly increased the hERG protein abundance within
the cell membrane. The effect was mimicked by treatment of hERG
expressing oocytes with recombinant klotho protein.
The effect of klotho on hERG channels may result at least in part
from its enzyme activity. Klotho has glucuronidase activity [5].
Klotho has been shown to up-regulate epithelial Ca2+ channels
TRPV5 [16,32,33] and the renal outer medullary K+ channel ROMK
[17] by its enzyme activity. It has been suggested that klotho
cleaves the terminal sialic acids from N-glycan chains of the chan-
nel proteins thus exposing the underlying disaccharide galactose-
N-acetylglucosamine [34]. The galactose-N-acetylglucosamine
binds galectin-1, which prevents internalization thus leading to
accumulation of the channels in the plasma membrane [34,34].
Moreover, full-length klotho has a chaperone-like effect on sur-
face-membrane expression of channels [35–37].
The effect of klotho on hERG protein abundance in the cell
membrane and thus on hERG channel activity presumablyinﬂuences the cardiac action potential. An increase of hERG activity
is expected to accelerate the repolarisation of ventricular cardio-
myocytes and shorten the action potential. Klotho deﬁciency is
expected to down-regulate hERG channel activity resulting in
delayed repolarisation. Whether or not the cardiac arrhythmia
and sudden cardiac death in klotho deﬁciency [2] is caused by
deranged regulation of ion channel activity, remains to be shown.
hERG channels are down-regulated in cardiac hypertrophy
[20,38], an effect mediated by activation of AT1 receptors with sub-
sequent activation of protein kinase C linked to the PKC pathway in
ventricular cardiomyocytes [39]. It may be of interest whether
treatment with klotho could reverse the down-regulation of hERG
channel activity in cardiac hypertrophy.
hERG channels are further known to facilitate tumour growth
[21–23]. At least in theory, the up-regulation of hERG by klotho
could thus foster tumour development.
In conclusion, klotho participates in the regulation of the volt-
age-gated K+ channel hERG. Klotho enhances hERG activity, an ef-
fect apparently requiring glucuronidase activity.
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Fig. 4. Effect of klotho inhibitor DSAL on current in hERG and klotho expressing Xenopus oocytes. (A) Original tracings recorded in oocytes expressing hERG without (2) or
with klotho without (3) or with (4) a 24 h pretreatment with klotho inhibitor DSAL (10 lM). The pulse protocol is illustrated in (1): the oocytes were depolarized from a
holding potential of 80 mV to different voltages followed by a 500 ms pulse to 60 mV evoking outward tail currents. (B) Arithmetic means ± S.E.M. (n = 6–12) of the
normalized leak-corrected peak tail current as a function of voltage in oocytes injected with water (grey diamonds), or expressing hERG alone (white circles) or expressing
hERG and klotho without treatment (black circles) or treated for 24 h with klotho inhibitor DSAL (grey circles). (C) Arithmetic means ± S.E.M. (n = 6–12) of the normalized tail
current following a depolarization to +70 mV recorded in water injected oocytes (dotted bar), expressing hERG alone (white bar) or expressing hERG with klotho without
treatment (black bar) or with (grey bar) pretreatment with d-saccharic acid-1,4-lactone (DSAL, 24 h 10 lM). ⁄⁄⁄ indicates statistical signiﬁcant (P < 0.001) difference from
oocytes expressing hERG alone. # indicates statistical signiﬁcant (p<0.05) difference from oocytes co-expressing hERG and Klotho without DSAL treatment.
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